SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-065170
Filing Date
2018-12-18
Accepted
2018-12-18 16:59:49
Documents
1
Period of Report
2018-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv509180_form4.html 4  
1 FORM 4 tv509180_form4.xml 4 10161
  Complete submission text file 0001144204-18-065170.txt   11525
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10017
Business Address
Litchman Manuel MD (Reporting) CIK: 0001709485 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38191 | Film No.: 181241140